Working together to advance cell manufacturing
Transforming the manufacture of cell-based therapeutics into a large-scale, lower-cost, reproducible, and high-quality engineered process, for broad industry and clinical use.
A partnership with the National
Cell Manufacturing Consortium
Researchers have received funding to screen and evaluate adjuvants that may improve the ability of coronavirus vaccines to simulate the immune system.
Krishnendu Roy and Johnna Temenoff lead a NSF Engineering Research Center at Tech
NSF grant to fund study of factors that help underrepresented students